Tenderwize
Wróć do wyszukiwania

Open-house biologics rebate agreement for PEG-Epoetin beta

Techniker Krankenkasse·Hamburg, Germany·Deadline Jan 30, 2028 · 520 days left·Open·Supplies
Zarejestruj się, aby zapisaćOpen documents
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-38 - PEG-Epoetin beta

52/100

Ocena szansy

Needs reviewMedium complexity
SuppliesOpen
Skąd ta ocena?

Szansa

52 / 100

Złożoność

58 / 100

Czynniki ryzyka

For monthly inclusion in pharmacy software, complete documents must reach TK by the 3rd day of the previous month; late...

Portal submission is not allowed; contracts must be sent by email with qualified electronic signature or by post, which...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until Jan 2028
  • Supply of pharmaceutical products for PEG-Epoetin beta under an open-house rebate agreement.
  • Conclusion of rebate contracts with all suitable pharmaceutical manufacturers meeting the stated conditions.
Pokaż pełne podsumowanie

Open-house supply arrangement for PEG-Epoetin beta pharmaceutical products in Germany, led by Techniker Krankenkasse with HEK and hkk as participating buyers. The contract is non-exclusive, with no individual negotiations, and can be joined at any time during the contract period. The notice states a maximum duration of 24 months from 01.02.2026 to 31.01.2028. No contract value is provided. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post, and the notice says the procurement documents are available online but were not fully analyzed as separate extracted document text is not provided beyond the XML notice.

Ryzyka

For monthly inclusion in pharmacy software, complete documents must reach TK by the 3rd day of the previous month; late...

Portal submission is not allowed; contracts must be sent by email with qualified electronic signature or by post, which...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Applicant must be a pharmaceutical undertaking within the meaning of § 4 Abs. 18 AMG for the relevant medicinal product.
  • Applicant must have its seat in the AMG territory, another EU Member State, or another EEA state.
  • Applicant must hold a valid marketing authorisation for the relevant medicinal product or otherwise be entitled to place it on the market in its own name.

Zamawiający

Lokalizacja

Hamburg, DEU

Identyfikator

992-80116-93

Działalność

Health

Części (1)

LOT-0001

Open-house biologics rebate agreement for PEG-Epoetin beta

Open-house supply contract for rebate agreements under § 130c Abs. 1 SGB V for the active substance PEG-Epoetin beta. The lot is nationwide in Germany and is described as non-exclusive, with uniform conditions and no individual negotiations. The extracted XML notice indicates that contracts are opened directly and concluded once the stated conditions are met.

SuppliesEU fundedElectronic submission

Lokalizacja

DE600, Germany

Czas trwania

Jan 2026 - Jan 2028

Kategoria

Pharmaceutical products

Termin

Deadline Jan 30, 2028

Szczegóły zamówienia

Data publikacji
03 Dec 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
804419-2025

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30